Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
4.170
+0.020 (0.48%)
Aug 27, 2025, 3:33 PM - Market open
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $112.91 million as of August 27, 2025. Its market cap has decreased by -49.87% in one year.
Market Cap
112.91M
Enterprise Value
-9.50M
1-Year Change
-49.87%
Ranking
Category
Stock Price
$4.17
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has decreased from $528.69M to $112.91M, a decrease of -78.64%. That is a compound annual growth rate of -62.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 112.37M | -1.50% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |